Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590M
-
Number of holders
-
423
-
Total 13F shares, excl. options
-
93.3M
-
Shares change
-
-4.37M
-
Total reported value, excl. options
-
$8.01B
-
Value change
-
-$353M
-
Put/Call ratio
-
0.9
-
Number of buys
-
152
-
Number of sells
-
-221
-
Price
-
$85.84
Significant Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q2 2014
493 filings reported holding EW - Edwards Lifesciences Corp - Common Stock as of Q2 2014.
Edwards Lifesciences Corp - Common Stock (EW) has 423 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 93.3M shares
of 590M outstanding shares and own 15.81% of the company stock.
Largest 10 shareholders include Capital World Investors (12.1M shares), Capital Research Global Investors (10.8M shares), VANGUARD GROUP INC (7.43M shares), FMR LLC (6.73M shares), WELLINGTON MANAGEMENT CO LLP (4.95M shares), State Street Corp (4.62M shares), GENERATION INVESTMENT MANAGEMENT LLP (4.27M shares), BlackRock Institutional Trust Company, N.A. (2.74M shares), Fairpointe Capital LLC (1.62M shares), and BlackRock Fund Advisors (1.56M shares).
This table shows the top 423 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.